# RESVERLOGIX CORP.: Form D filings

RESVERLOGIX CORP., a biotechnology company in Calgary, Alberta, Alberta, Canada, filed 2 Form D notices with the SEC in 2011. The latest, on December 1, 2011, reports $1.8 million sold of a $1.8 million offering to 1 investor.

Find out what RESVERLOGIX CORP. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RESVERLOGIX%20CORP.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RESVERLOGIX%20CORP.&page=%2Fdata%2Fform-d%2Fcompany%2Fresverlogix-corp-1372821)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RESVERLOGIX%20CORP.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RESVERLOGIX%20CORP.&page=%2Fdata%2Fform-d%2Fcompany%2Fresverlogix-corp-1372821)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: SUITE 202, 279 MIDPARK WAY S.E., Calgary, Alberta, Alberta, Canada, T2X 1
- Phone: (403) 254-9252
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Alberta, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1372821

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 1, 2011 | New notice | $1,841,995 | $1,841,995 | $0 | 1 | Nov 29, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372821/000120445911003200/0001204459-11-003200-index.htm) |
| Jun 21, 2011 | New notice | $10,486,899 | $10,486,899 | $0 | 7 | Jun 14, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372821/000120445911001702/0001204459-11-001702-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kenneth J. Zuerblis | Director |  |
| Gregory S. Wagner | Executive Officer |  |
| Arthur J. Higgins | Director |  |
| Kenneth O. Lebioda | Executive Officer |  |
| A. Brad Cann | Executive Officer |  |
| Donald J. McCaffrey | Executive Officer, Director |  |
| Norman C.W. Wong | Executive Officer |  |
| Peter Allan Johann | Director |  |
| Kelly J. McNeill | Director |  |
| F. Allan Gordon | Executive Officer |  |
| Jan O. Johansson | Executive Officer |  |
| Eldon R. Smith | Director |  |

[Every Form D from the week of Nov 28, 2011](https://specstream.ai/data/form-d/week/2011-11-28) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what RESVERLOGIX CORP. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).